| Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA) KE Finberg, MM Heeney, DR Campagna, Y Aydınok, HA Pearson, ... Nature genetics 40 (5), 569-571, 2008 | 816 | 2008 |
| Definitions of the phenotypic manifestations of sickle cell disease SK Ballas, S Lieff, LJ Benjamin, CD Dampier, MM Heeney, C Hoppe, ... American journal of hematology 85 (1), 6-13, 2010 | 530 | 2010 |
| Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to … RE Ware, BR Davis, WH Schultz, RC Brown, B Aygun, S Sarnaik, I Odame, ... The Lancet 387 (10019), 661-670, 2016 | 492 | 2016 |
| Common variants at 10 genomic loci influence hemoglobin A1C levels via glycemic and nonglycemic pathways N Soranzo, S Sanna, E Wheeler, C Gieger, D Radke, J Dupuis, ... Diabetes 59 (12), 3229-3239, 2010 | 485 | 2010 |
| Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease EB Esrick, LE Lehmann, A Biffi, M Achebe, C Brendel, MF Ciuculescu, ... New England Journal of Medicine 384 (3), 205-215, 2021 | 344 | 2021 |
| Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD) PK Chakraborty, K Schmitz-Abe, EK Kennedy, H Mamady, T Naas, ... Blood, The Journal of the American Society of Hematology 124 (18), 2867-2871, 2014 | 194 | 2014 |
| Hydroxyurea for children with sickle cell disease MM Heeney, RE Ware Hematology/oncology clinics of North America 24 (1), 199-214, 2010 | 176 | 2010 |
| Lineage-specific BCL11A knockdown circumvents toxicities and reverses sickle phenotype C Brendel, S Guda, R Renella, DE Bauer, MC Canver, YJ Kim, ... The Journal of clinical investigation 126 (10), 3868-3878, 2016 | 173 | 2016 |
| A multinational trial of prasugrel for sickle cell vaso-occlusive events MM Heeney, CC Hoppe, MR Abboud, B Inusa, J Kanter, B Ogutu, ... New England Journal of Medicine 374 (7), 625-635, 2016 | 148 | 2016 |
| Hydroxyurea for the treatment of sickle cell disease: efficacy, barriers, toxicity, and management in children JJ Strouse, MM Heeney Pediatric blood & cancer 59 (2), 365-371, 2012 | 148 | 2012 |
| Sickle cell detection using a smartphone SM Knowlton, I Sencan, Y Aytar, J Khoory, MM Heeney, IC Ghiran, ... Scientific reports 5 (1), 15022, 2015 | 135 | 2015 |
| A novel syndrome of congenital sideroblastic anemia, B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD) DH Wiseman, A May, S Jolles, P Connor, C Powell, MM Heeney, ... Blood, The Journal of the American Society of Hematology 122 (1), 112-123, 2013 | 115 | 2013 |
| Iron-refractory iron deficiency anemia (IRIDA) MM Heeney, KE Finberg Hematology/Oncology Clinics 28 (4), 637-652, 2014 | 103 | 2014 |
| Bacteremia risk and outpatient management of febrile patients with sickle cell disease MN Baskin, XL Goh, MM Heeney, MB Harper Pediatrics 131 (6), 1035-1041, 2013 | 92 | 2013 |
| Long‐term safety and efficacy of deferasirox (Exjade®) for up to 5 years in transfusional iron‐overloaded patients with sickle cell disease E Vichinsky, F Bernaudin, GL Forni, R Gardner, K Hassell, MM Heeney, ... British journal of haematology 154 (3), 387-397, 2011 | 89 | 2011 |
| Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial KJ Helton, RJ Adams, KL Kesler, A Lockhart, B Aygun, C Driscoll, ... Blood, The Journal of the American Society of Hematology 124 (6), 891-898, 2014 | 87 | 2014 |
| Corticosteroids for acute chest syndrome in children with sickle cell disease: variation in use and association with length of stay and readmission A Sobota, DA Graham, MM Heeney, EJ Neufeld American Journal of Hematology 85 (1), 24-28, 2010 | 87 | 2010 |
| Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome ER Smith, CD McClain, M Heeney, RM Scott Neurosurgical Focus 26 (4), E10, 2009 | 85 | 2009 |
| Successful hematopoietic stem cell mobilization and apheresis collection using plerixafor alone in sickle cell patients EB Esrick, JP Manis, H Daley, C Baricordi, H Trébéden-Negre, FJ Pierciey, ... Blood advances 2 (19), 2505-2512, 2018 | 82 | 2018 |
| Transition from pediatric to adult care for sickle cell disease: results of a survey of pediatric providers A Sobota, EJ Neufeld, P Sprinz, MM Heeney American journal of hematology 86 (6), 512, 2011 | 82 | 2011 |
Baba (PDB) Inusapaediatric haematology在 gstt.nhs.uk 的电子邮件经过验证
